Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate in Idiopathic Hypersomnia
NCT03597555Phase 3Completed
- Sponsor
- CHU Montpellier
- Start
- Oct 2018
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium oxybate in idiopathic hypersomnia (IH), sponsored by CHU Montpellier. Started Oct 2018; status: completed.
02
Drugs
sodium oxybate
03
Conditions
idiopathic hypersomnia (IH)
Beyond the preview
Go deeper on NCT03597555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597555.